GlassScriptPhysician profile
David William Cundey
NPI 1952487324
$3,761.24
in general payments reported to CMS, 2019-2025
41 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $393 · 2021: $339 · 2022: $562 · 2023: $316 · 2024: $454 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,487.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $626.41 | 2019-2025 | |
| Pfizer INC. | $473.35 | 2019-2025 | |
| Amgen INC. | $327.72 | 2019-2025 | Repatha |
| Abbott Laboratories | $240.43 | 2019-2025 | Mitraclip, Triclip, Cardiomems |
| Janssen Pharmaceuticals, INC | $230.39 | 2019-2022 | |
| Boston Scientific Corporation | $208.91 | 2019-2025 | Cds Broad Portfolio Offering, General - Therapies |
| Inari Medical, INC. | $185.20 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $158.67 | 2019-2022 | |
| Abiomed | $111.90 | 2025 | |
| Astellas Pharma US INC | $109.14 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $97.54 | 2021-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $85.00 | 2021-2023 | Verquvo |
| Medtronic, INC. | $68.95 | 2021-2024 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Novo Nordisk INC | $68.58 | 2024-2025 | Wegovy |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cundey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.